The Recall Desk
Agency classClass IOur severity:SevereFDA (Drugs)·D-1338-2022·Announced 2022-07-27

Launch Sequence Aphrodisia Capsules recalled for undeclared tadalafil

Launch Sequence Aphrodisia Capsules contain undeclared tadalafil, making them an unapproved drug. The recall involves 500 4-count tins distributed nationwide in the USA and Canada.

The agency’s classification

FDA (Drugs): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: This is an FDA Class I recall of an unapproved drug containing undeclared tadalafil, a pharmaceutical ingredient that poses potential safety risks. The Class I classification mandates a minimum severity score of 4.

Plain-English summary

Launch Sequence Aphrodisia Capsules, manufactured by Loud Muscle Science, are being recalled due to the presence of undeclared tadalafil. Tadalafil is a pharmaceutical ingredient found in FDA-approved medications used for sexual enhancement, but was not disclosed on the product label.

This recall results from marketing the product without FDA approval. The capsules were sold without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), making them an unapproved drug. The recalled product is identified by lot number 2022104, with an expiration date of April 2025.

The affected product was distributed nationwide in the USA and Canada. Consumers who have purchased Launch Sequence Aphrodisia Capsules should refer to the FDA's drug recall website or contact the FDA for guidance on the product.

The recalled product

Product
Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # 2022104
  • exp. date 04/2025

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 6 recalled by Loud Muscle Science under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 6 products in this recall →

Similar recalls